AMS INSIGHT 1 Study - Bioabsorbable Metal Stent Investigation in Chronic Limb Ischemia Treatment

PHASE2CompletedINTERVENTIONAL
Enrollment

117

Participants

Timeline

Start Date

July 31, 2005

Study Completion Date

January 31, 2007

Conditions
Peripheral Artery Disease
Interventions
DEVICE

MAGIC EXPLORER (Biotronik AG)

The lesion is pre-dilated with the PLEON EXPLORER balloon with a length of 10 mm or 15 mm or 20 mm under angiographic control. After dilation, the stenosed area is treated by one AMS implant. If the implanted stent is not fully apposed to the vessel wall or if initial angiography reveals a residual stenosis, the stent may be post-dilated with the delivery system balloon. If necessary, a high-pressure, non-compliant balloon catheter may be used.

DEVICE

PLEON EXPLORER (Biotronik AG)

The lesion is dilated with the PLEON EXPLORER balloon with lengths of 10 mm or 15 mm or 20 mm, respectively. In case that the PTA procedure results in a residual stenosis of \>50%, the AMS implant should be used to improve the result. A flow-limiting dissection does not qualify for stenting. Best effort must be made to obtain a satisfactory result (e.g. multiple and prolonged inflations) before a patient in the PTA group can be treated with a stent.

Trial Locations (12)

9200

AZ St-Blasius, Dendermonde

Unknown

Medizinische Universität Graz, Graz

A.ö. Landeskrankenhaus Klagenfurt, Klagenfurt

Allgem. Krankenhaus Vienna, Vienna

Universitair Ziekenhuis Antwerpen, Antwerp

Imelda Ziekenhuis Bonheiden, Bonheiden

Herzzentrum Bad Krozingen, Bad Krozingen

Humaine Kliniken Bad Saarow, Bad Saarow

Ev. Krankenhaus Herberge Berlin, Berlin

Universitätsklinikum Leipzig, Leipzig

Universitätsklinikum Mainz, Mainz

Sint-Elisabeth Ziekenhuis Tilburg, Tilburg

All Listed Sponsors
collaborator

Biotronik SE & Co. KG

INDUSTRY

lead

Flanders Medical Research Program

NETWORK

NCT00572494 - AMS INSIGHT 1 Study - Bioabsorbable Metal Stent Investigation in Chronic Limb Ischemia Treatment | Biotech Hunter | Biotech Hunter